TY - JOUR
AR - COR-2020-3-103
TI - Common Prognostic Scoring Systems for Patients Presenting with Brain Metastases
AU - Ahmet Kucuk, 
AU - Berrin Pehlivan, 
AU - Duygu Sezen, 
AU - Erkan, Topkan
AU - Esma Didem Ikiz, 
AU - Eyub Yasar Aydemir, 
AU - Nulifer Kılıc Durankus, 
AU - Sukran Senyurek, 
AU - Ugur Selek, 
AU - Yasemin Bolukbasi, 
JO - Clinical Oncology and Research
PY - 2020
DA - Tue 17, Mar 2020
SN - 2613-4942
DO - http://dx.doi.org/10.31487/j.COR.2020.03.03
UR - https://www.sciencerepository.org/common-prognostic-scoring-systems_COR-2020-3-103 
KW - Brain metastasis, scoring systems, prognosis, survival
AB - Brain metastases (BM) of various primaries merely remain the most prevalent type of intracranial tumors, and approximately 25% of all cancer patients are diagnosed with this poor prognostic disease condition somewhere during their treatment course. Contingent upon the general wellbeing status of the potential patient, currently available major treatment options typically include palliative radiotherapy, chemotherapy, and best supportive care. Various published studies have convincingly shown the likelihood to stratify BM patients into particular prognostic gatherings according to the conceivable combinations of multiple patients- and tumor-related characteristics; namely the prognostic scoring systems, which might be useful in the accurate prediction of survival, and thusly, the appropriate choice of the best-fit treatment alternative. In this present article, we meant to review the pros and cons of the as of now accessible and broadly acknowledged prognostic scoring systems for BMs and their clinical values.